RBC Capital Maintains Outperform on Insulet, Lowers Price Target to $160

Benzinga · 1d ago
RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $245 to $160.